{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:45:45Z","timestamp":1791823545775,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24se0123004"],"award-info":[{"award-number":["JP24se0123004"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24bk0304007"],"award-info":[{"award-number":["JP24bk0304007"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bioscience and Bioengineering"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jbiosc.2026.08.007","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T19:53:28Z","timestamp":1788983608000},"page":"430-438","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of transfection optimization on adeno-associated virus purification performance and vector quality"],"prefix":"10.1016","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3081-2935","authenticated-orcid":false,"given":"Ekaputra","family":"Ramadhani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7366-7610","authenticated-orcid":false,"given":"Yasuo","family":"Tsunaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuko","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5181-179X","authenticated-orcid":false,"given":"Susumu","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbiosc.2026.08.007_bib1","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.ymthe.2022.03.004","article-title":"Durability of transgene expression after rAAV gene therapy","volume":"30","author":"Muhuri","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib2","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1002\/jcph.2141","article-title":"Clinical pharmacology considerations on recombinant adeno-associated virus\u2013based gene therapy","volume":"62","author":"Sun","year":"2022","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-024-01780-w","article-title":"Adeno-associated virus as a delivery vector for gene therapy of human diseases","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib4","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.ymthe.2025.03.064","article-title":"AAV vector development, back to the future","volume":"33","author":"Suarez-Amaran","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib5","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1016\/j.ymthe.2018.07.011","article-title":"Systemic AAV micro-dystrophin gene therapy for Duchenne Muscular Dystrophy","volume":"26","author":"Duan","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1182\/blood-2018-07-820720","article-title":"Update on clinical gene therapy for hemophilia","volume":"133","author":"Perrin","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jbiosc.2026.08.007_bib7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2020.11.001","article-title":"Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy","volume":"74","author":"Chand","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2016.2","article-title":"Manufacturing of recombinant adeno-associated viral vectors for clinical trials","volume":"3","author":"Cl\u00e9ment","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108433","article-title":"The state of technological advancement to address challenges in the manufacture of rAAV gene therapies","volume":"76","author":"Destro","year":"2024","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.149122","article-title":"The unveiled novel regulator of adeno-associated virus production in HEK293 cells","volume":"938","author":"Yan","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.jbiosc.2026.08.007_bib11","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.omtm.2021.02.010","article-title":"Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies","volume":"20","author":"Gimpel","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2021.107764","article-title":"Cellular pathways of recombinant adeno-associated virus production for gene therapy","volume":"49","author":"Sha","year":"2021","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib13","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.omtm.2021.04.006","article-title":"Mechanistic model for production of recombinant adeno-associated virus via triple transfection of HEK293 cells","volume":"21","author":"Nguyen","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.753467","article-title":"Adeno-associated viruses (AAV) and host immunity \u2013 a race between the hare and the hedgehog","volume":"12","author":"Rapti","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib15","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMoa2307798","article-title":"Death after high-dose rAAV9 gene therapy in a patient with Duchenne\u2019s muscular dystrophy","volume":"389","author":"Lek","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1128\/jvi.8.5.766-770.1971","article-title":"Structural proteins of adenovirus-associated viruses","volume":"8","author":"Rose","year":"1971","journal-title":"J. Virol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib17","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1038\/s41467-021-21935-5","article-title":"Adeno-associated virus capsid assembly is divergent and stochastic","volume":"12","author":"W\u00f6rner","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib18","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1128\/JVI.78.12.6595-6609.2004","article-title":"Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus","volume":"78","author":"Warrington","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib19","doi-asserted-by":"crossref","first-page":"11040","DOI":"10.1128\/JVI.01056-06","article-title":"Adeno-associated virus type 2 capsids with externalized VP1\/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus","volume":"80","author":"Sonntag","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib20","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.omtm.2017.11.002","article-title":"A robust system for production of superabundant VP1 recombinant AAV vectors","volume":"7","author":"Wang","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101142","article-title":"Enhancement of recombinant adeno-associated virus activity by improved stoichiometry and homogeneity of capsid protein assembly","volume":"31","author":"Onishi","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101581","article-title":"Variation of VP2 stoichiometry and deamidation of VP1 during production and their impacts on the transduction efficiency of AAV vectors","volume":"33","author":"Maruno","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib23","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/btpr.67","article-title":"Bioprocess optimization using design-of-experiments methodology","volume":"24","author":"Mandenius","year":"2008","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/03639045.2017.1291672","article-title":"Design of experiments (DoE) in pharmaceutical development","volume":"43","author":"Politis","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.omtm.2020.06.004","article-title":"Creation of a high-yield AAV vector production platform in suspension cells using a design-of-experiment approach","volume":"18","author":"Zhao","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib26","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1002\/bit.28508","article-title":"Design space determination to optimize DNA complexation and full capsid formation in transient rAAV manufacturing","volume":"120","author":"Fu","year":"2023","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3445","article-title":"High-yield recombinant adeno-associated viral vector production by multivariate optimization of bioprocess and transfection conditions","volume":"40","author":"Coplan","year":"2024","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00449-025-03167-9","article-title":"Improved productivity of recombinant adeno-associated virus (rAAV) via triple transfection of HEK293 cells using perfusion cultivation","volume":"48","author":"Nie","year":"2025","journal-title":"Bioprocess Biosyst. Eng."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib29","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s12033-013-9725-x","article-title":"Addition of valproic acid to CHO cell fed-batch cultures improves monoclonal antibody titers","volume":"56","author":"Yang","year":"2014","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3390\/molecules25020353","article-title":"High-Throughput screening identifies two novel small molecule enhancers of recombinant protein expression","volume":"25","author":"Chang","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.jbiosc.2026.08.007_bib31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0022-1759(00)00308-2","article-title":"Butyrate increases production of human chimeric IgG in CHO-K1 cells whilst maintaining function and glycoform profile","volume":"247","author":"Mimura","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.jbiosc.2026.08.007_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jbiotec.2007.06.009","article-title":"The histone deacetylase inhibitor sodium butyrate inhibits baculovirus-mediated transgene expression in Sf9 cells","volume":"131","author":"Peng","year":"2007","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202200450","article-title":"Increased recombinant adeno-associated virus production by HEK293 cells using small molecule chemical additives","volume":"18","author":"Scarrott","year":"2023","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/hum.2022.153","article-title":"Process development of recombinant adeno-associated virus production platform results in high production yield and purity","volume":"34","author":"Zhao","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib36","first-page":"3","article-title":"From clinical trials to clinical practice: practical considerations for gene replacement therapy in SMA type 1. Pediatr","volume":"100","author":"Al-Zaidy","year":"2019","journal-title":"Neurol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.yamp.2020.07.017","article-title":"Precision therapies in neurodevelopmental disorders","volume":"3","author":"Uddin","year":"2020","journal-title":"Adv. Mol. Pathol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib38","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/978-1-4939-9213-3_19","article-title":"Highly sensitive SDS capillary gel electrophoresis with sample stacking requiring only nanograms of adeno-associated virus capsid proteins","volume":"1972","author":"Zhang","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.omtm.2017.12.004","article-title":"Universal method for the purification of recombinant AAV vectors of differing serotypes","volume":"9","author":"Nass","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101377","article-title":"Structural characterization and epitope mapping of the AAVX affinity purification ligand","volume":"32","author":"Mietzsch","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib41","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3390\/ijms25020838","article-title":"Automated mass photometry of adeno-associated virus vectors from crude cell extracts","volume":"25","author":"Wagner","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300051","article-title":"Production of adeno-associated viral vector serotype 6 by triple transfection of suspension HEK293 cells at higher cell densities","volume":"18","author":"Mo\u00e7o","year":"2023","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1208\/s12248-025-01194-8","article-title":"Quantifying the full-to-empty adeno-associated virus (AAV) capsid ratios and their impact on transduction efficiency in vitro","volume":"28","author":"Hoyle","year":"2026","journal-title":"AAPS J."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib44","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/bit.28980","article-title":"Development of an HEK293 suspension cell culture medium, transient transfection optimization workflow, and analytics for batch rAAV manufacturing","volume":"122","author":"Green","year":"2025","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib45","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/mt.2015.187","article-title":"Production of recombinant adeno-associated virus vectors using suspension HEK293 cells and continuous harvest of vector from the culture media for GMP FIX and FLT1 clinical vector","volume":"24","author":"Grieger","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib46","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.3390\/molecules23102564","article-title":"Systematic screening of commonly used commercial transfection reagents towards efficient transfection of single-stranded oligonucleotides","volume":"23","author":"Wang","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.jbiosc.2026.08.007_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202300667","article-title":"Enhancing the production of adeno-associated virus (AAV)2 and AAV9 with high full capsid ratio in HEK293 cells through design-of-experiment optimization of triple plasmid ratio","volume":"19","author":"Park","year":"2024","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108370","article-title":"Unravelling the essential elements for recombinant adeno-associated virus (rAAV) production in animal cell-based platforms","volume":"73","author":"Catal\u00e1n-Tatjer","year":"2024","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2024.108322","article-title":"Decoding cellular mechanism of recombinant adeno-associated virus (rAAV) and engineering host-cell factories toward intensified viral vector manufacturing","volume":"71","author":"Wang","year":"2024","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib50","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1089\/hum.2022.116","article-title":"Significant differences in capsid properties and potency between adeno-associated virus vectors produced in Sf9 and HEK293 cells","volume":"34","author":"Giles","year":"2023","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib51","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/pharmaceutics13050748","article-title":"Comparison of different liquid chromatography-based purification strategies for adeno-associated virus vectors","volume":"13","author":"Rieser","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jbiosc.2026.08.007_bib52","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.omtm.2022.12.009","article-title":"High-efficiency purification of divergent AAV serotypes using AAVX affinity chromatography","volume":"28","author":"Florea","year":"2023","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jbiosc.2026.08.007_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101441","article-title":"A two-pass anion-exchange chromatography strategy for enrichment of full capsids in manufacturing of adeno-associated viral vectors","volume":"33","author":"Thakur","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."}],"container-title":["Journal of Bioscience and Bioengineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389172326002768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389172326002768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:54:08Z","timestamp":1791820448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389172326002768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1389172326002768"],"URL":"https:\/\/doi.org\/10.1016\/j.jbiosc.2026.08.007","relation":{},"ISSN":["1389-1723"],"issn-type":[{"value":"1389-1723","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of transfection optimization on adeno-associated virus purification performance and vector quality","name":"articletitle","label":"Article Title"},{"value":"Journal of Bioscience and Bioengineering","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbiosc.2026.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Society for Biotechnology, Japan. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}